0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lipid Microbubble Contrast Agent Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27K15381
Home | Market Reports | Health| Medical Devices & Equipment
Global Lipid Microbubble Contrast Agent Market Research Report 2023
BUY CHAPTERS

Global Lipid Microbubble Contrast Agent Market Research Report 2025

Code: QYRE-Auto-27K15381
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lipid Microbubble Contrast Agent Market Size

The global market for Lipid Microbubble Contrast Agent was valued at US$ 622 million in the year 2024 and is projected to reach a revised size of US$ 871 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Lipid Microbubble Contrast Agent Market

Lipid Microbubble Contrast Agent Market

Lipid microbubble contrast agent is a drug or substance commonly used in medical imaging to image blood vessels or tissues. This contrast agent is composed primarily of lipids (usually phospholipids) and is often coated with a gas or other contrast agent.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lipid Microbubble Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Microbubble Contrast Agent.
The Lipid Microbubble Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Microbubble Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Microbubble Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lipid Microbubble Contrast Agent Market Report

Report Metric Details
Report Name Lipid Microbubble Contrast Agent Market
Accounted market size in year US$ 622 million
Forecasted market size in 2031 US$ 871 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical, Qihui Biology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lipid Microbubble Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lipid Microbubble Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Lipid Microbubble Contrast Agent Market growing?

Ans: The Lipid Microbubble Contrast Agent Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Lipid Microbubble Contrast Agent Market size in 2031?

Ans: The Lipid Microbubble Contrast Agent Market size in 2031 will be US$ 871 million.

Who are the main players in the Lipid Microbubble Contrast Agent Market report?

Ans: The main players in the Lipid Microbubble Contrast Agent Market are Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical, Qihui Biology

What are the Application segmentation covered in the Lipid Microbubble Contrast Agent Market report?

Ans: The Applications covered in the Lipid Microbubble Contrast Agent Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Lipid Microbubble Contrast Agent Market report?

Ans: The Types covered in the Lipid Microbubble Contrast Agent Market report are Micron, Nanoscale

Recommended Reports

Ultrasound Imaging Markets

Contrast Agent Technologies

Lipid-Based Technologies

1 Lipid Microbubble Contrast Agent Market Overview
1.1 Product Definition
1.2 Lipid Microbubble Contrast Agent by Type
1.2.1 Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Micron
1.2.3 Nanoscale
1.3 Lipid Microbubble Contrast Agent by Application
1.3.1 Global Lipid Microbubble Contrast Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Lipid Microbubble Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Lipid Microbubble Contrast Agent Revenue 2020-2031
1.4.2 Global Lipid Microbubble Contrast Agent Sales 2020-2031
1.4.3 Global Lipid Microbubble Contrast Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lipid Microbubble Contrast Agent Market Competition by Manufacturers
2.1 Global Lipid Microbubble Contrast Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lipid Microbubble Contrast Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lipid Microbubble Contrast Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lipid Microbubble Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lipid Microbubble Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lipid Microbubble Contrast Agent, Product Type & Application
2.7 Global Key Manufacturers of Lipid Microbubble Contrast Agent, Date of Enter into This Industry
2.8 Global Lipid Microbubble Contrast Agent Market Competitive Situation and Trends
2.8.1 Global Lipid Microbubble Contrast Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lipid Microbubble Contrast Agent Players Market Share by Revenue
2.8.3 Global Lipid Microbubble Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lipid Microbubble Contrast Agent Market Scenario by Region
3.1 Global Lipid Microbubble Contrast Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lipid Microbubble Contrast Agent Sales by Region: 2020-2031
3.2.1 Global Lipid Microbubble Contrast Agent Sales by Region: 2020-2025
3.2.2 Global Lipid Microbubble Contrast Agent Sales by Region: 2026-2031
3.3 Global Lipid Microbubble Contrast Agent Revenue by Region: 2020-2031
3.3.1 Global Lipid Microbubble Contrast Agent Revenue by Region: 2020-2025
3.3.2 Global Lipid Microbubble Contrast Agent Revenue by Region: 2026-2031
3.4 North America Lipid Microbubble Contrast Agent Market Facts & Figures by Country
3.4.1 North America Lipid Microbubble Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lipid Microbubble Contrast Agent Sales by Country (2020-2031)
3.4.3 North America Lipid Microbubble Contrast Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lipid Microbubble Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Lipid Microbubble Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lipid Microbubble Contrast Agent Sales by Country (2020-2031)
3.5.3 Europe Lipid Microbubble Contrast Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lipid Microbubble Contrast Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Lipid Microbubble Contrast Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lipid Microbubble Contrast Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lipid Microbubble Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Lipid Microbubble Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lipid Microbubble Contrast Agent Sales by Country (2020-2031)
3.7.3 Latin America Lipid Microbubble Contrast Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lipid Microbubble Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Lipid Microbubble Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lipid Microbubble Contrast Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lipid Microbubble Contrast Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lipid Microbubble Contrast Agent Sales by Type (2020-2031)
4.1.1 Global Lipid Microbubble Contrast Agent Sales by Type (2020-2025)
4.1.2 Global Lipid Microbubble Contrast Agent Sales by Type (2026-2031)
4.1.3 Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2020-2031)
4.2 Global Lipid Microbubble Contrast Agent Revenue by Type (2020-2031)
4.2.1 Global Lipid Microbubble Contrast Agent Revenue by Type (2020-2025)
4.2.2 Global Lipid Microbubble Contrast Agent Revenue by Type (2026-2031)
4.2.3 Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2020-2031)
4.3 Global Lipid Microbubble Contrast Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lipid Microbubble Contrast Agent Sales by Application (2020-2031)
5.1.1 Global Lipid Microbubble Contrast Agent Sales by Application (2020-2025)
5.1.2 Global Lipid Microbubble Contrast Agent Sales by Application (2026-2031)
5.1.3 Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2020-2031)
5.2 Global Lipid Microbubble Contrast Agent Revenue by Application (2020-2031)
5.2.1 Global Lipid Microbubble Contrast Agent Revenue by Application (2020-2025)
5.2.2 Global Lipid Microbubble Contrast Agent Revenue by Application (2026-2031)
5.2.3 Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2020-2031)
5.3 Global Lipid Microbubble Contrast Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lantheus Medical Imaging
6.1.1 Lantheus Medical Imaging Company Information
6.1.2 Lantheus Medical Imaging Description and Business Overview
6.1.3 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Product Portfolio
6.1.5 Lantheus Medical Imaging Recent Developments/Updates
6.2 Bracco SpA
6.2.1 Bracco SpA Company Information
6.2.2 Bracco SpA Description and Business Overview
6.2.3 Bracco SpA Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco SpA Lipid Microbubble Contrast Agent Product Portfolio
6.2.5 Bracco SpA Recent Developments/Updates
6.3 GE Healthcare
6.3.1 GE Healthcare Company Information
6.3.2 GE Healthcare Description and Business Overview
6.3.3 GE Healthcare Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GE Healthcare Lipid Microbubble Contrast Agent Product Portfolio
6.3.5 GE Healthcare Recent Developments/Updates
6.4 Daiichi Sankyo Company
6.4.1 Daiichi Sankyo Company Company Information
6.4.2 Daiichi Sankyo Company Description and Business Overview
6.4.3 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Product Portfolio
6.4.5 Daiichi Sankyo Company Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Lipid Microbubble Contrast Agent Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Guerbet Group
6.6.1 Guerbet Group Company Information
6.6.2 Guerbet Group Description and Business Overview
6.6.3 Guerbet Group Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Guerbet Group Lipid Microbubble Contrast Agent Product Portfolio
6.6.5 Guerbet Group Recent Developments/Updates
6.7 Hengrui Medicine
6.7.1 Hengrui Medicine Company Information
6.7.2 Hengrui Medicine Description and Business Overview
6.7.3 Hengrui Medicine Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hengrui Medicine Lipid Microbubble Contrast Agent Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates
6.8 BeiLu Pharmaceutical
6.8.1 BeiLu Pharmaceutical Company Information
6.8.2 BeiLu Pharmaceutical Description and Business Overview
6.8.3 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Product Portfolio
6.8.5 BeiLu Pharmaceutical Recent Developments/Updates
6.9 Qihui Biology
6.9.1 Qihui Biology Company Information
6.9.2 Qihui Biology Description and Business Overview
6.9.3 Qihui Biology Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qihui Biology Lipid Microbubble Contrast Agent Product Portfolio
6.9.5 Qihui Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lipid Microbubble Contrast Agent Industry Chain Analysis
7.2 Lipid Microbubble Contrast Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lipid Microbubble Contrast Agent Production Mode & Process Analysis
7.4 Lipid Microbubble Contrast Agent Sales and Marketing
7.4.1 Lipid Microbubble Contrast Agent Sales Channels
7.4.2 Lipid Microbubble Contrast Agent Distributors
7.5 Lipid Microbubble Contrast Agent Customer Analysis
8 Lipid Microbubble Contrast Agent Market Dynamics
8.1 Lipid Microbubble Contrast Agent Industry Trends
8.2 Lipid Microbubble Contrast Agent Market Drivers
8.3 Lipid Microbubble Contrast Agent Market Challenges
8.4 Lipid Microbubble Contrast Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lipid Microbubble Contrast Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lipid Microbubble Contrast Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lipid Microbubble Contrast Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lipid Microbubble Contrast Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lipid Microbubble Contrast Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lipid Microbubble Contrast Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lipid Microbubble Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lipid Microbubble Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Microbubble Contrast Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lipid Microbubble Contrast Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lipid Microbubble Contrast Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lipid Microbubble Contrast Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Lipid Microbubble Contrast Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lipid Microbubble Contrast Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Lipid Microbubble Contrast Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lipid Microbubble Contrast Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Lipid Microbubble Contrast Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lipid Microbubble Contrast Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Lipid Microbubble Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lipid Microbubble Contrast Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lipid Microbubble Contrast Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lipid Microbubble Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lipid Microbubble Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lipid Microbubble Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lipid Microbubble Contrast Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lipid Microbubble Contrast Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lipid Microbubble Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lipid Microbubble Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lipid Microbubble Contrast Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lipid Microbubble Contrast Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lipid Microbubble Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lipid Microbubble Contrast Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lipid Microbubble Contrast Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lipid Microbubble Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lipid Microbubble Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lipid Microbubble Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lipid Microbubble Contrast Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lipid Microbubble Contrast Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lipid Microbubble Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lipid Microbubble Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lipid Microbubble Contrast Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Lipid Microbubble Contrast Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lipid Microbubble Contrast Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Lipid Microbubble Contrast Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Lantheus Medical Imaging Company Information
 Table 71. Lantheus Medical Imaging Description and Business Overview
 Table 72. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Product
 Table 74. Lantheus Medical Imaging Recent Developments/Updates
 Table 75. Bracco SpA Company Information
 Table 76. Bracco SpA Description and Business Overview
 Table 77. Bracco SpA Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bracco SpA Lipid Microbubble Contrast Agent Product
 Table 79. Bracco SpA Recent Developments/Updates
 Table 80. GE Healthcare Company Information
 Table 81. GE Healthcare Description and Business Overview
 Table 82. GE Healthcare Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GE Healthcare Lipid Microbubble Contrast Agent Product
 Table 84. GE Healthcare Recent Developments/Updates
 Table 85. Daiichi Sankyo Company Company Information
 Table 86. Daiichi Sankyo Company Description and Business Overview
 Table 87. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Product
 Table 89. Daiichi Sankyo Company Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Lipid Microbubble Contrast Agent Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Guerbet Group Company Information
 Table 96. Guerbet Group Description and Business Overview
 Table 97. Guerbet Group Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Guerbet Group Lipid Microbubble Contrast Agent Product
 Table 99. Guerbet Group Recent Developments/Updates
 Table 100. Hengrui Medicine Company Information
 Table 101. Hengrui Medicine Description and Business Overview
 Table 102. Hengrui Medicine Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hengrui Medicine Lipid Microbubble Contrast Agent Product
 Table 104. Hengrui Medicine Recent Developments/Updates
 Table 105. BeiLu Pharmaceutical Company Information
 Table 106. BeiLu Pharmaceutical Description and Business Overview
 Table 107. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Product
 Table 109. BeiLu Pharmaceutical Recent Developments/Updates
 Table 110. Qihui Biology Company Information
 Table 111. Qihui Biology Description and Business Overview
 Table 112. Qihui Biology Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Qihui Biology Lipid Microbubble Contrast Agent Product
 Table 114. Qihui Biology Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Lipid Microbubble Contrast Agent Distributors List
 Table 118. Lipid Microbubble Contrast Agent Customers List
 Table 119. Lipid Microbubble Contrast Agent Market Trends
 Table 120. Lipid Microbubble Contrast Agent Market Drivers
 Table 121. Lipid Microbubble Contrast Agent Market Challenges
 Table 122. Lipid Microbubble Contrast Agent Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lipid Microbubble Contrast Agent
 Figure 2. Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lipid Microbubble Contrast Agent Market Share by Type: 2024 & 2031
 Figure 4. Micron Product Picture
 Figure 5. Nanoscale Product Picture
 Figure 6. Global Lipid Microbubble Contrast Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lipid Microbubble Contrast Agent Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Lipid Microbubble Contrast Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Lipid Microbubble Contrast Agent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Lipid Microbubble Contrast Agent Sales (2020-2031) & (K Units)
 Figure 14. Global Lipid Microbubble Contrast Agent Average Price (US$/Unit) & (2020-2031)
 Figure 15. Lipid Microbubble Contrast Agent Report Years Considered
 Figure 16. Lipid Microbubble Contrast Agent Sales Share by Manufacturers in 2024
 Figure 17. Global Lipid Microbubble Contrast Agent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Lipid Microbubble Contrast Agent Players: Market Share by Revenue in Lipid Microbubble Contrast Agent in 2024
 Figure 19. Lipid Microbubble Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Lipid Microbubble Contrast Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Lipid Microbubble Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 22. North America Lipid Microbubble Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 23. United States Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Lipid Microbubble Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 26. Europe Lipid Microbubble Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Lipid Microbubble Contrast Agent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Lipid Microbubble Contrast Agent Revenue Market Share by Region (2020-2031)
 Figure 34. China Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Lipid Microbubble Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Lipid Microbubble Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Lipid Microbubble Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Lipid Microbubble Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Lipid Microbubble Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Lipid Microbubble Contrast Agent by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Lipid Microbubble Contrast Agent by Type (2020-2031)
 Figure 53. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Lipid Microbubble Contrast Agent by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Lipid Microbubble Contrast Agent by Application (2020-2031)
 Figure 56. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2020-2031)
 Figure 57. Lipid Microbubble Contrast Agent Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart